Nexalin Technology, Inc. (NXLIW)
USD 0.17
(20.14%)
USD 0.17
(20.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 110.74 Thousand USD | -91.62% |
| 2022 | 1.32 Million USD | 817.2% |
| 2021 | 144.06 Thousand USD | -40.69% |
| 2020 | 242.91 Thousand USD | 17.13% |
| 2019 | 207.38 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 26.84 Thousand USD | -65.88% |
| 2024 Q1 | 78.67 Thousand USD | 283.09% |
| 2023 Q4 | 20.53 Thousand USD | -14.83% |
| 2023 FY | 110.74 Thousand USD | -91.62% |
| 2023 Q3 | 24.11 Thousand USD | -32.15% |
| 2023 Q2 | 35.54 Thousand USD | 16.3% |
| 2023 Q1 | 30.56 Thousand USD | -20.47% |
| 2022 Q2 | 414.28 Thousand USD | 28.13% |
| 2022 Q1 | 323.32 Thousand USD | 1247.23% |
| 2022 FY | 1.32 Million USD | 817.2% |
| 2022 Q4 | 38.42 Thousand USD | -92.95% |
| 2022 Q3 | 545.32 Thousand USD | 31.63% |
| 2021 Q3 | 55.97 Thousand USD | 91.99% |
| 2021 FY | 144.06 Thousand USD | -40.69% |
| 2021 Q4 | 23.99 Thousand USD | -57.12% |
| 2021 Q2 | 29.15 Thousand USD | -16.57% |
| 2021 Q1 | 34.94 Thousand USD | 7.51% |
| 2020 Q2 | 86.75 Thousand USD | -0.0% |
| 2020 FY | 242.91 Thousand USD | 17.13% |
| 2020 Q4 | 32.5 Thousand USD | -11.93% |
| 2020 Q3 | 36.9 Thousand USD | -57.46% |
| 2020 Q1 | 86.75 Thousand USD | 0.0% |
| 2019 FY | 207.38 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 98.454% |
| Cerus Corporation | 156.36 Million USD | 99.929% |
| OrthoPediatrics Corp. | 148.73 Million USD | 99.926% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | 88.567% |
| Talis Biomedical Corporation | 412 Thousand USD | 73.119% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 99.198% |
| Inogen, Inc. | 315.66 Million USD | 99.965% |
| Spectral AI, Inc. | 18.05 Million USD | 99.387% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 98.882% |
| CVRx, Inc. | 39.29 Million USD | 99.718% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | 82.803% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.985% |
| Venus Concept Inc. | 76.35 Million USD | 99.855% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 99.082% |
| Bioventus Inc. | 512.34 Million USD | 99.978% |
| BrainsWay Ltd. | 31.78 Million USD | 99.652% |
| Envoy Medical, Inc. | 316 Thousand USD | 64.953% |
| electroCore, Inc. | 16.03 Million USD | 99.309% |
| IceCure Medical Ltd | 3.22 Million USD | 96.57% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 95.439% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | 69.658% |
| MaxCyte, Inc. | 41.28 Million USD | 99.732% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 94.328% |
| PAVmed Inc | 2.45 Million USD | 95.483% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 99.508% |
| RxSight, Inc. | 89.07 Million USD | 99.876% |
| Sight Sciences, Inc. | 81.05 Million USD | 99.863% |
| SI-BONE, Inc. | 138.88 Million USD | 99.92% |
| TELA Bio, Inc. | 58.45 Million USD | 99.811% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 99.402% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 99.941% |
| LivaNova PLC | 1.15 Billion USD | 99.99% |
| 908 Devices Inc. | 50.22 Million USD | 99.78% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.977% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -43.746% |
| NeuroPace, Inc. | 65.42 Million USD | 99.831% |
| LENSAR, Inc. | 42.16 Million USD | 99.737% |
| Apyx Medical Corporation | 52.34 Million USD | 99.788% |
| Cutera, Inc. | 212.36 Million USD | 99.948% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 99.668% |
| BioSig Technologies, Inc. | 18 Thousand USD | -515.267% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 99.934% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 99.538% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.993% |
| Axonics, Inc. | 366.37 Million USD | 99.97% |
| Outset Medical, Inc. | 130.37 Million USD | 99.915% |
| IRIDEX Corporation | 51.86 Million USD | 99.786% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.919% |
| IRadimed Corporation | 65.56 Million USD | 99.831% |
| Tivic Health Systems, Inc. | 1.17 Million USD | 90.583% |
| INVO Bioscience, Inc. | 3.02 Million USD | 96.334% |
| Telesis Bio, Inc. | 27.5 Million USD | 99.597% |
| Viemed Healthcare, Inc. | 183 Million USD | 99.939% |
| Varex Imaging Corporation | 811 Million USD | 99.986% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.95% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 99.839% |
| Dynatronics Corporation | 32.53 Million USD | 99.66% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 98.724% |
| Semler Scientific, Inc. | 68.18 Million USD | 99.838% |
| InMode Ltd. | 492.04 Million USD | 99.977% |
| Bruker Corporation | 2.96 Billion USD | 99.996% |
| Cytosorbents Corporation | 36.34 Million USD | 99.695% |
| DexCom, Inc. | 3.62 Billion USD | 99.997% |
| Align Technology, Inc. | 3.86 Billion USD | 99.997% |
| Viveve Medical, Inc. | 6.42 Million USD | 98.277% |
| ZimVie Inc. | 457.43 Million USD | 99.976% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 99.943% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | 0.0% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.985% |
| Profound Medical Corp. | 7.33 Million USD | 98.489% |
| Insulet Corporation | 1.69 Billion USD | 99.993% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 99.912% |
| iCAD, Inc. | 17.31 Million USD | 99.361% |
| Nuwellis, Inc. | 8.86 Million USD | 98.751% |
| Biotricity, Inc. | 12.06 Million USD | 99.082% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.978% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 98.215% |
| PAVmed Inc. | 2.45 Million USD | 95.483% |
| BIOLASE, Inc. | 49.16 Million USD | 99.775% |
| Beyond Air, Inc. | 1.15 Million USD | 90.445% |
| FONAR Corporation | 102.88 Million USD | 99.892% |
| AxoGen, Inc. | 159.01 Million USD | 99.93% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.96% |
| Inari Medical, Inc. | 493.63 Million USD | 99.978% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.972% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -495.419% |
| Tenon Medical, Inc. | 2.92 Million USD | 96.218% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 98.374% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.997% |
| Sintx Technologies, Inc. | 2.62 Million USD | 95.784% |
| NanoVibronix, Inc. | 2.28 Million USD | 95.149% |
| Quanterix Corporation | 122.36 Million USD | 99.909% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 99.546% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.945% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.954% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 99.201% |
| NeuroMetrix, Inc. | 5.9 Million USD | 98.123% |
| Hyperfine, Inc. | 11.03 Million USD | 98.996% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 99.933% |
| Biomerica, Inc. | 5.41 Million USD | 97.955% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 99.781% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 99.937% |